IPO - Neurogene Inc.

Form Type: CORRESP

Filing Date: 2024-12-12

Corporate Action: Ipo

Type: New

Accession Number: 000162828024050972

Filing Summary: Neurogene Inc. submitted a request to the United States Securities and Exchange Commission for the acceleration of the effective time of their Registration Statement on Form S-1, originally filed on December 2, 2024. The company seeks to have the statement declared effective at 4:01 p.m. Eastern Time on December 16, 2024, or soon thereafter, contingent upon their outside counsel's request for any changes. Neurogene acknowledges its obligations under the Securities Act of 1933 as it proceeds with this IPO registration process.